Evidence map›Paper›PMID 41630820›Full record

ArticleJournal of clinical medicine research2026

Long-Term Mental Health Evaluation After COVID-19: Insights From the CARDIO COVID 20-21 Registry.

Juan Carlos Rivas Nieto, Brayan Daniel Cordoba-Melo, Juan Pablo Arango-Ibanez, Sebastian Seni-Molina, Mario Miguel Barbosa Rengifo, Carlos Alberto Miranda-Bastidas, Andres Felipe Casanova Rojas, Andres Fernando Mina Sanchez, Cesar J Herrera, Miguel Angel Quintana Da Silva and 5 more

Abstract read
In one paragraph

Article in Journal of clinical medicine research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Juan Carlos Rivas NietoServicio de Psiquiatría, Fundación Valle del Lili, Cali, Colombia.
Brayan Daniel Cordoba-MeloCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Juan Pablo Arango-IbanezCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Sebastian Seni-MolinaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Mario Miguel Barbosa RengifoCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Carlos Alberto Miranda-BastidasDepartamento de Psiquiatría, Universidad del Valle, Cali, Colombia.
Andres Felipe Casanova RojasCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Andres Fernando Mina SanchezCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
Cesar J HerreraDepartamento de Cardiología, Centros de Diagnóstico y Medicina Avanzada y de Conferencias Médicas y Telemedicina (CEDIMAT), Santo Domingo, República Dominicana.
Miguel Angel Quintana Da SilvaDepartamento de Cardiología, Instituto Cardiovascular Sanatorio MIGONE, Asunción, Paraguay.
Andres Felipe BuitragoDepartamento de Cardiología, Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Maria Lorena Coronel GilioDepartamento de Cardiología, Instituto de Cardiología Juana Francisca Cabral, Corrientes, Argentina.
Freddy Pow-Chon-LongDepartamento de Cardiología, Hospital Luis Vernaza, Guayaquil, Ecuador.
Juan Esteban Gomez-MesaCentro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.
CARDIO COVID 20–21 Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Psychopathological manifestations are key features of long COVID, contributing to a considerable global mental health burden. Neuropsychiatric sequelae such as anxiety, depression, cognitive dysfunction, and perceived stress may persist for months or years after infection. Latin American populations remain underrepresented, despite a high prevalence of long COVID and unique socio-demographic characteristics. Understanding these impacts is essential for targeted screening and interventions. Methods: We conducted a prospective study of patients hospitalized for severe COVID-19. Psychiatric evaluation used the General Anxiety Disorder-7, Patient Health Questionnaire-9, Perceived Stress Scale-14, and Addenbrooke's Cognitive Examination-III (ACE-III), at an average of 24.5 months post-illness. Bivariate analyses evaluated differences by sex and intensive care unit (ICU) admission. Multivariable linear regression was used to examine associations between cognitive scores and age, sex, education, socioeconomic status, ICU admission, body mass index, smoking exposure, hypertension, and diabetes. Results: We included 152 patients; the mean age was 56 years, and 58.5% were male. Anxiety symptoms were present in 33%, depression in 49%, and both perceived stress and cognitive dysfunction were each observed in 11% of patients. Women exhibited significantly higher levels of depression (P = 0.02) and stress (P = 0.011), whereas patients admitted to the ICU demonstrated greater cognitive impairment (P < 0.001). In multivariable regression, male sex (P = 0.002), higher education (P < 0.001), and hypertension (P = 0.037) were significantly associated with higher ACE-III scores, while ICU admission was associated with lower scores (P = 0.017). Conclusion: Our study reveals a high prevalence of mental health symptoms and cognitive dysfunction among patients 2 years after severe COVID-19. Anxiety showed no differences by sex or ICU requirement. Women exhibited higher rates of depression and perceived stress, while ICU admission was associated with poorer cognitive performance. Our findings should encourage systematic screening, diagnosis, and management of long-term neuropsychiatric sequelae in COVID-19 survivors. However, due to the limitations of the single-center design, further longitudinal and multicenter studies are warranted to better elucidate the long-term psychiatric impact of COVID-19.

Indexed as

AnxietyCognitive dysfunctionCOVID-19DepressionLong COVIDStress

Identifiers

PMID41630820
PMCPMC12861518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.